Maintenance of autoantibody production in pristane-induced murine lupus
Open Access
- 30 December 2015
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 17 (1) , 1-13
Abstract
Pristane-treated mice chronically produce high levels of anti-ribonucleoprotein/Smith (anti-Sm/RNP) and other lupus autoantibodies. The present study addressed how these autoantibody levels are maintained over time. Lupus was induced in BALB/c mice using pristane. Naïve B cells, switched memory B cells, switched plasmablasts, and plasma cells were flow-sorted and total IgG and anti-U1A (RNP) autoantibodies were determined with ELISA. B cells with a switched “memory-like” (CD19+CD138−IgM−IgD−) (sMB) phenotype were increased in pristane-treated mice and expressed higher levels of Toll like receptor 7 (Tlr7) than cells with this phenotype from untreated mice. Flow-sorted sMB cells from pristane-treated mice did not secrete IgG spontaneously, but were hyper-responsive to both synthetic (R848) and natural (apoptotic cells) TLR7 ligands, resulting in increased IgG production in vitro. The flow-sorted sMB cells also could be driven by R848 to produce IgG anti-U1A autoantibodies. Production of IgG was strongly inhibited by both JSH-23 and SB203580, suggesting that the canonical NFκB and p38 MAPK pathways, respectively, contribute to the TLR7 ligand hyper-responsiveness of sMB from pristane-treated mice. The switched memory B cell subset from pristane-treated mice is expanded and shows an increased propensity to undergo terminal (plasma cell) differentiation in response to synthetic and natural TLR7 ligands. The data suggest that the decreased clearance of apoptotic cells characteristic of pristane-treated mice might help maintain high serum levels of anti-RNP/Sm autoantibodies.Keywords
This publication has 55 references indexed in Scilit:
- Integration of B cell responses through Toll-like receptors and antigen receptorsNature Reviews Immunology, 2012
- Unc93B1 Restricts Systemic Lethal Inflammation by Orchestrating Toll-like Receptor 7 and 9 TraffickingImmunity, 2011
- Toll-like receptor driven B cell activation in the induction of systemic autoimmunitySeminars in Immunology, 2011
- Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center ResponseImmunity, 2011
- FcγRIIB regulation of BCR/TLR‐dependent autoreactive B‐cell responsesEuropean Journal of Immunology, 2010
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbonsTrends in Immunology, 2009
- Phenotypic and functional heterogeneity of human memory B cellsSeminars in Immunology, 2008
- Control of Toll-like Receptor 7 Expression Is Essential to Restrict Autoimmunity and Dendritic Cell ProliferationImmunity, 2007
- Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptorsSeminars in Immunology, 2007
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006